TREM2, in contrast, has been confirmed to represent a candidate gene for PD susceptibility and progression, and soluble TREM2 (sTREM2) expression in cerebrospinal fluid was increased in PD patients, suggesting sTREM2 in CSF as a substitute immune biomarker for PD neuron injury23. This evidence concerns the gene TREM2 and Parkinson disease.